Tumor Size as a Critical Prognostic Factor in T1-2 Stage Esophageal Cancer.

Conclusion: The current study identified tumor size as a critical clinical prognostic signature for esophageal cancer with considerable discriminatory ability and prognostic value. Therefore, tumor size should be included in the American Joint Committee on Cancer (AJCC) TNM staging of T1-2 esophagus cancer patients. PMID: 32879626 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32879626?dopt=Abstract

Source: Gastroenterology Research and Practice - September 4, 2020 Category: Gastroenterology Tags: Gastroenterol Res Pract Source Type: research